• Products
  • Suppliers
  • Sourcing Requests
Post Sourcing Request Exhibition
Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising
New Products
water filter
WATER FILTER FOR WATER PURIFIER
DUST BAG
Small dust filter
HUMIDIFIER FILTER
Oil fume adsorption filter

US FDA completes inspection of Lupin’s Nagpur plant

financialexpressMay 21, 2018

Tag: US , FDA , Lupin’s Nagpur plant

Lupin said the US health regulator has completed inspection of its Nagpur facility without making any observations.

In a BSE filing, Lupin "announced successful completion of an inspection carried out by the United States Food and Drug Administration (US FDA) at its Nagpur facility. The inspection concluded without any observations".

Lupin said its Nagpur facility manufactures oral solid products.

Register as Visitor to CPhI China 2018!

Previous:IPGA felicitates Dilip Sanghvi, MD, Sun Pharma

Next:9-valent HPV Vaccine will Go through Customs at RMB 1,298/Piece and be Marketed Next Month!

Related News

Thrombolytic Science Announces FDA’s IND Clearance of Mutant Prourokinase for the Treatment of Thrombotic Diseases

PharmaSourcesOctober 15, 2024

Thrombolytic Science, LLC (TSI), announced today that the U.S. Food and Drug Administration (FDA) has cleared its Investigational New Drug (IND) application for mutant prourokinase, a recombinant fibrinolytic pro-enzyme.

Eleva Appoints Dr. Elisabeth Lackner to its Supervisory Board Adding Broad Biopharmaceutical Industry Expertise to the Organization

PharmaSourcesOctober 15, 2024

BrainDos™ Formulated Dual GIP/GLP-1 Receptor Agonist Tirzepatide Outperforms Tirzepatide Solution (Mounjaro®) in Preclinical Study

PharmaSourcesOctober 15, 2024

US FDA completes inspection of Lupin’s Nagpur plant | Pharmasources.com

BD and ten23 health® Partner to Advance Efficiency and Quality in Aseptic Manufacturing with RFID-Enabled Prefillable Syringes

PharmaSourcesOctober 15, 2024

BD and ten23 health today announced a collaboration to develop a new way to track prefillable syringes (PFS) using RFID technology.

You may like
More>>

Pentoxifylline Sustained Release Tablets

Pentoxifylline Sustained Release Tablets
Benzocaine BP/USP Pharmaceutical Analgesic ulcer and hemorrhoids made in china

Benzocaine BP/USP Pharmaceutical Analgesic ulcer and hemorrhoids made in china
Ferrous   sulfate sugar-coated Tablets

Ferrous   sulfate sugar-coated Tablets
Lactobacillus acidophilus

Lactobacillus acidophilus
Recombinant Mouse C-C Motif Chemokine Ligand 11

Recombinant Mouse C-C Motif Chemokine Ligand 11
Recombinant Mouse C-C Motif Chemokine Ligand 7

Recombinant Mouse C-C Motif Chemokine Ligand 7
Ferrous citrate

Ferrous citrate
Polygonum Cuspidatum Extract Powder 50%

Polygonum Cuspidatum Extract Powder 50%
Kushenol I

Kushenol I
Customied Enzyme Modification Solutions

Customied Enzyme Modification Solutions

Contact Us

PharmaSources@imsinoexpo.com

Tel: (+86) 400 610 1188

WhatsApp/Telegram/Wechat: +86 13621645194

About Us
About PharmaSources
Terms of Service
Privacy Policy
Intellectual Property
Media Partners
Buy
Search Products
Post Sourcing Requests
Search Suppliers
CAS Search
Sell
Member Application
Advertising
Post Products
EZSourcing
Events
CPHI China
PMEC China
Conferences
Search Events
Help
FAQ
Contact Us
Feedback
PharmaSources Customer Service